The Medicines (Sale or Supply) (Miscellaneous Provisions) Amendment (No. 2) Regulations 1997

Amendment of regulation 8 of the Medicines (Sale or Supply) (Miscellaneous Provisions) Regulations 1980

2.  In regulation 8 of the Medicines (Sale or Supply) (Miscellaneous Provisions) Regulations 1980(1) (pack size on retail sale or supply of certain products on a general sale list)—

(a) in paragraph (1), for “paragraphs (2) to (2C) and (3)” there is substituted “paragraphs (2) to (2E) and (3)”;

(b) in paragraph (2)—

(i) for “aloxiprin, aspirin, paracetamol or salicylamide” there is substituted “aloxiprin, aspirin or paracetamol”,

(ii) for subparagraph (b) there is substituted—

“(b) in the case of tablets that are not effervescent—

(i) where they do not contain aspirin or paracetamol, not more than 25 tablets,

(ii) where they contain aspirin, paracetamol or both of those substances, not more than 16 tablets;”,

(iii) for subparagraph (d) there is substituted—

“(d) in the case of capsules—

(i) where they do not contain aspirin or paracetamol, not more than 25 capsules,

(ii) where they contain aspirin, paracetamol or both of those substances, not more than 16 capsules; and”,

(iv) after subparagraph (d) add the following subparagraph—

“(e) in the case of liquid preparations of paracetamol—

(i) which are intended for persons aged 12 years and over, not more than 160 millilitres of the product, or

(ii) which are intended for persons aged less than 12 years, individual unit doses of not more than 5 millilitres each, to a maximum of 20 unit doses.”; and

(c) after paragraph (2C) there are inserted the following paragraphs—

“(2D) Where a medicinal product for human use containing sodium picosulphate is sold by retail in the course of a business elsewhere than at a registered pharmacy or is so offered or exposed for sale by retail or so supplied in circumstances corresponding to retail sale, the product shall be presented for sale in a separate and individual container or package containing not more than 60 millilitres of the product.

(2E) Where a medicinal product for human use containing loperamide hydrochloride is sold by retail in the course of a business elsewhere than at a registered pharmacy or is so offered or exposed for sale by retail or so supplied in circumstances corresponding to retail sale, the product shall be presented for sale in a separate and individual container or package containing not more than 6 tablets or capsules.”.

(1)

S.I. 1980/1923; relevant amending instruments are S.I. 1982/28, 1990/1124, 1994/2411 and 1995/3215.